title: Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT.
authors: Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors: M
authors: M
authors: Jung
authors: Department of Hematology and Oncology, Washington Hospital Center, Washington, DC, USA.
authors: V N
authors: VN
authors: Ranpura
authors: Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors: C E
authors: CE
authors: Dunbar
authors: Molecular and Clinical Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors: J F
authors: JF
authors: Tisdale
authors: Molecular and Clinical Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors: C D
authors: CD
authors: Fitzhugh
authors: Molecular and Clinical Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors: M M
authors: MM
authors: Hsieh
mesh_terms: D000328:Adult; D064591:Allografts; D000755:Anemia, Sickle Cell / Q000628:therapy*; D000799:Angioedema / Q000139:chemically induced*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D020123:Sirolimus